CVS Health Corporation (CVS)
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health: Health Insurers Get Buffett's Stamp Of Approval (Rating Upgrade)
Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the sector's business model remains intact despite recent headwinds. CVS has emerged as a top performer in 2025, with strong revenue growth and raised guidance, outpacing struggling peers like UnitedHealth. The sector faces ongoing uncertainties—rising costs, regulatory scrutiny, and budget cuts—but long-term healthcare spending trends remain favorable.
CVS Advances Digital Efforts to Simplify Healthcare Experience
CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
CVS appears well-poised on strong Q2 revenue growth, raised full-year guidance and momentum in key healthcare segments.
5 Low Price-to-Book Stocks to Add to Your Portfolio in August
STNE, CVS, KT, KB and USNA stand out in August for low P/B ratios and strong growth forecasts, making them value stock contenders.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
3 Medical Stocks to Consider as Markets Take a Breather
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.
CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up
CVS is focusing heavily on technology-led care after posting solid Q2 earnings. “We are building momentum as we navigate what continues to be a dynamic and evolving environment,” Chief Executive David Joyner told analysts on an earnings call Thursday (July 31), crediting the company's “diversified business” for offsetting swings in medical costs.
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.
